Skip to main content

Advertisement

Log in

Treatment disparities following the diagnosis of an astrocytoma

  • Clinical Study – Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Post-operative radiation and chemotherapy following diagnosis of astrocytoma are standard care. No research has examined racial or insurance-based disparities in treatment receipt. The purpose of this study was to evaluate whether African Americans and patients with dual eligibility in Medicare and Medicaid (DE), compared to Caucasians and patients with Medicare alone, experienced differences in (1) seeing a radiation oncologist, (2) receiving radiation or chemotherapy, and (3) overall survival. Using a retrospective descriptive design, statewide Medicaid and Medicare data were merged with the Michigan Tumor Registry to extract a sample of patients (n = 604) ≥65 years old with a first primary astrocytoma diagnosis in Michigan between 1996 and 2000. There were no racial or insurance-based differences in reporting a claim for a radiation oncologist. Controlling for age, income, surgical intervention, residence population, comorbidities, gender, and stage, African Americans were less likely to report radiation claims than Caucasians (OR = 0.20; 95% CI = 0.07–0.54). DE patients were less likely to report radiation claims (OR = 0.50; 95% CI = 0.26–0.94) than those with Medicare only. These differences were not seen with chemotherapy. When only those with a glioblastoma multiforme were examined, DE patients (OR = 0.47; 95% CI = 0.24–0.92) and African Americans (OR = 0.13; 95% CI = 0.04–0.44) were much less likely to report radiation claims. Race and insurance status did not significantly affect survival, although income did. Data suggest disparities in race and insurance status may exist in receiving standard of care for astrocytomas. Further research is warranted to replicate the data and determine potential sources for these disparities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. CBTRUS (2008) Statistical report: primary brain tumors in the United States, 2000–2004. Central Brain Tumor Registry of the United States, Chicago

  2. NCCN (2008) Central nervous system cancers, vol 1. National Comprehensive Cancer Network Inc

  3. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  CAS  PubMed  Google Scholar 

  4. Kennedy J, Tuleu I, Mackay K (2008) Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm 14:553–560

    PubMed  Google Scholar 

  5. Basu J (2001) Access to primary care: the role of race and income. J Health Soc Policy 13:57–73

    Article  CAS  PubMed  Google Scholar 

  6. McCall DT, Sauaia A, Hamman RF, Reusch JE, Barton P (2004) Are low-income elderly patients at risk for poor diabetes care? Diabetes Care May 27:1060–1065

    Article  Google Scholar 

  7. Sambamoorthi U, Collins S, Crystal S (2001) Dually eligible individuals with AIDS: characteristics and health services use. J Health Soc Policy 14:19–35

    Article  CAS  PubMed  Google Scholar 

  8. Bradley CJ, Dahman B, Given CW (2008) Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid. J Clin Oncol 26:5067–5073

    Article  PubMed  Google Scholar 

  9. Walsh EG, Clark WD (2002) Managed care and dually eligible beneficiaries: challenges in coordination. Health Care Financ Rev 24:63–82

    PubMed  Google Scholar 

  10. Ryan J, Super N (2003) Dually eligible for Medicare and Medicaid: two for one or double jeopardy? Issue Brief Natl Health Policy Forum 794: 1–24

    Google Scholar 

  11. Groeneveld PW, Laufer SB, Garber AM (2005) Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989–2000. Med Care 43:320–329

    Article  PubMed  Google Scholar 

  12. Mark TL, Axelsen KJ, Mucha L, Sadkova Y (2007) Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients. Am J Manag Care 13(Suppl 3):S72–S79

    PubMed  Google Scholar 

  13. Percy C, Shanmugratnam K, Whelan S, Parkin DM, Jack A, Fritz A, Sobin L (2005) ICD-O international classification of diseases for oncology, 3rd edn. World Health Organization, Switzerland

  14. Buck C (2008) 2009 ICD-9-CM, vol 1, 2, & 3. Saunders, Philadelphia

  15. Allison PD (2001) Missing data. Sage Publications, Thousand Oaks, CA

    Google Scholar 

  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  CAS  PubMed  Google Scholar 

  17. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619

    Article  CAS  PubMed  Google Scholar 

  18. Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258–1267

    Article  CAS  PubMed  Google Scholar 

  19. Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G (2006) In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 44:745–753

    Article  PubMed  Google Scholar 

  20. Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527–1535

    Article  CAS  PubMed  Google Scholar 

  21. Magrini SM, Ricardi U, Santoni R et al (2006) Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 Italian radiation oncology centers. Int J Radiat Oncol Biol Phys 65:788–799

    Article  PubMed  Google Scholar 

  22. Chang SM, Parney IF, Huang W et al (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557–564

    Article  CAS  PubMed  Google Scholar 

  23. Zhang H, Kane RL, Dowd B, Feldman R (2008) Selection bias and utilization of the dual eligibles in Medicare and Medicaid HMOs. Health Serv Res

  24. Carcaise-Edinboro P, Bradley CJ (2008) Influence of patient-provider communication on colorectal cancer screening. Med Care 46:738–745

    Article  PubMed  Google Scholar 

  25. Green AR, Peters-Lewis A, Percac-Lima S et al (2008) Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 23:834–840

    Article  PubMed  Google Scholar 

  26. White A, Liu CC, Xia R et al (2008) Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer 113:3400–3409

    Article  PubMed  Google Scholar 

  27. Kim SH, Ferrante J, Won BR, Hameed M (2008) Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment. World J Surg Oncol 6:26

    Article  PubMed  Google Scholar 

  28. Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD (2008) Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst 100:738–744

    Article  PubMed  Google Scholar 

  29. Masi CM, Gehlert S (2009) Perceptions of breast cancer treatment among African-American women and men: implications for interventions. J Gen Intern Med 24:408–414

    Article  PubMed  Google Scholar 

  30. Barnholtz-Sloan JS, Williams VL, Maldonado JL et al (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108:642–648

    Article  PubMed  Google Scholar 

  31. Robertson JT, Gunter BC, Somes GW (2002) Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 16:562–566

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Cancer Institute (R01-CA101835-01; C.J. Bradley, Principal Investigator).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paula R. Sherwood.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherwood, P.R., Dahman, B.A., Donovan, H.S. et al. Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol 101, 67–74 (2011). https://doi.org/10.1007/s11060-010-0223-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0223-8

Keywords

Navigation